While the 'good-risk 70-genes signature' [49] was developed to predict freedom from metastasis in a top-down manner and validated in the same dataset of breast cancer patients from the NKI, the IGF-I induced signature is a marker for poor prognosis and is well connected to a defined in vitro biological system. The gene discussed is IGF1; the disease is breast carcinoma.